Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2022-10-12 00:00:00 ET · period of report 2022-10-07 · accession 0001714899-22-000135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-10-12 | 2022-10-07 | DNLI | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.68 | +20.0K | 487.5K | +4% | +$13.6K |
| D | 2022-10-12 | 2022-10-07 | DNLI | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.00 | -20.0K | 220.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-07 | M | A | 20,000 | $0.68 | 487,471 | I See footnote | — | — | (F1) Exercised shares were issued to the Schuth Family Trust. (F2) The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. |
| 2 | Derivative | Stock Option (right to buy) | 2022-10-07 | M | D | 20,000 | $0.00 | 220,078 | D | $0.68 · — to 2025-08-20 | 20,000 Common Stock | (F4) The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018. |